Imbalance of VEGF family serum levels and receptors in patients with inflammatory bowel disease

Bratislava Medical Journal

Volumn 111, Issue 8, 2010, Pages 439-442

  Kemik, O ^a   Sarbay Kemik, A ^b   Purysa, S ^b   Tuzun, S ^c  

^a Haseki Training and Research Hospital   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c YUZUNCU YIL UNIVERSITY   (Turkey)

Author keywords

Inflammatory bowel disease; Receptor; Vascular endothelial growth factor

Indexed keywords

C REACTIVE PROTEIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ADULT; AGED; ARTICLE; BLOOD; ENTERITIS; FEMALE; HUMAN; MALE; MIDDLE AGED; PROGNOSIS;

ADULT; AGED; C-REACTIVE PROTEIN; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; PROGNOSIS; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 77956925215     PISSN: 00069248     EISSN: 13360345     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Otrock ZK, Makarem JA, Shamseddine AI. Vascular endothelial growth factor family of ligands and receptors: review. Blood Cells Mol Dis 2007; 38: 258-268.
2. Moreira IS, Fernandes PA, Ramos MJ. Vascular endothelial growth factor (VEGF) inhibition-a critical review. Anticancer Agents Med Chem 2007; 7: 223-245.
3. Simiantonaki N, Taxeidis M, Jayasinghe C, Kirkpatrick CJ. Epithelial expression of VEGF receptors in colorectal carcinomas and their relationship to metastatic status. Anticancer Res 2007; 27: 3245-3250.
4. von Lampe B, Barthel B, Coupland SE, Riecken EO, Rosewicz S. Differential expression of matrix metalloproteinases and their inhibitors in colon mucosa of patients with inflammatory bowel disease Gut 2000; 47: 63-73.
5. Arihiro S, Ohtani H, Hiwatashi N, Torii A, Sorsa T, Nagura H. Vascular smooth muscle cells and pericytes express MMP-1, MMp-9, TIMP-1 and type 1 procollagen in inflammatory bowel disease. Histopathology 2001; 39: 50-59.
6. Best WR, Becktel JM, Singleton LW, Kern F Jr. Development of Crohn's disease activity index. National cooperative Crohn's disease study. Gastroenterolgy 1976; 70: 439-444.
7. Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: A randomized trial. BMJ 1989; 298(6666): 82-86.
8. Karayiannakis AJ, Syrigos KN, Polychronidis A et al. Circulating VEGF levels in the srum of gazstric cancer patients: correlation with pathological variables, patient survival, and tumor surgery. Ann Surg 2002; 236: 37-42.
9. Zhao HC, Qin R, Chen XX, Sheng X, Wu JF, Wang DB, Chen GH. Microvessel density is a prognostic marker of human gastric cancer. World J Gastroenterol 2006; 12: 7598-7603.